BSECompany Update5d ago · 7 Aug 2026, 08:10 pm
Newspaper Advertisement
Biocon Ltd · 532523
✦ AI SummaryResults
Biocon Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 43,360 million, profit before tax at Rs. 1,276 million, and profit attributable to shareholders at Rs. 1,411 million.
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
696f2a68-c01b-425d-a9db-6f9fb04d0fc1.pdf
View document text
~$Biocon
Biocon Limited
20th KM, Hosur Road
Electronic City
Bangalore 560 100, India
T 91 80 2808 2808
F 91 80 2852 3423
CIN : L24234KA1978PLC003417
www.biocon.com
BIO/SECL/TG/2026-27/55
August 07, 2026
To, To,
The Manager The Manager
BSE Limited National Stock Exchange of India Limited
Department of Corporate Services Corporate Communication Department
Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai – 400 001 Mumbai – 400 051
Scrip Code - 532523 Scrip Symbol – Biocon
Subject: Newspaper Advertisement - Financial Results for the quarter ended June 30, 2026
Dear Sir/Madam,
In continuation to our letter dated August 05, 2026 with regard to Financial Results for the quarter ended
June 30, 2026, please find enclosed copies of newspaper advertisement published in Financial Express
(English Language-All India Edition) and Vijayavani (Kannada-Bengaluru Edition) on August 07, 2026.
The advertisement also includes a Quick Response code and the weblink to access complete financial results
for the said period. The above information is also available on the website of the Company at
www.biocon.com.
Kindly take the above information on record and acknowledge.
Thanking You,
Yours faithfully,
For Biocon Limited
Rajesh U. Shanoy
Company Secretary and Compliance officer
ICSI Membership Number: A16328
Enclosed: Copies of Newspaper advertisements
WWW.FINANCIALEXPRESS.COtv1 FRIDAY, AUGUST 7, 2026
FINANCIAL EXPRESS
3 mort !je{l Ye11rended
Particulars 30.06
Un:n.Ml Uruutdi
e from o eratiom; 70 39, 9
II fore ex~1lon ltemsand a:.; 8 08 1, 1
Ill 4.479 969
3,856 3 4
shareholde 9,130 .22,993 (1,735)
\JI l"ald•u s.5~] 8, 48 8,105 s,&as
VII R_$er I 3,32.213
VIII Earnin ea.cil] (not aooualised) jru'lnualised) (n~ amualised}
(a) Bes·,. 0.87 2.S2 □.lo
b) Diuled' 1187 2.B2 0.26
1. Key slandalon~ financial ildorm>i1,~1on
3 months e-nootll Yc.ar nded 3 months oncled
Particulars 30.06.21326 31 .O.:J.20'26 30.,06,2025
Unaudite ed Ul'lia'udlt'etl
I iRevanue from o eratians 6,245 23,464 sJn
II P oft befOffi tax ~ 51D (76
Ill t>J P.oflHot lhe period 522 312 133)
2. Tho unatdlfld !l!anl.falono and conrolidal:4!d flnaocial m.sults for 100 q er rMl!d Juoo 30, 2026 In mspect of Bioeoo milf:d ('IM
Company') hav1;1 b ·,•iE,,, ed by e A Co 11too and approw!d by _ Board of D.-eclore. of the C ny a1 tnelr respaci ve
meetings Id Oil AugusW5, 2026 er~ • 5il!ilut04':,· auditors are u ied.
3 These-financial es !shave Ileen ep-aredinaocon;limce'flilll lndianAco:amlillg S1a s(' AS')prescrib under Sec.( lllofthe
Compaflil!$ A.ci 2013 and -Other acCtll.Jn g principles g1Jnera acoop,.Bd I lndla arid In tefflls of Reg.Jtai 33 or 1ho SEH.l (us g
Cblig~tionsan 1'.'11:¾iosureR mm· ,~)A~ 1t1 ,20t5.
e abcWe is an extraci Of detailed .o at of uoo1Jdited Financial Results filed\\~ lhe Stock Erdlanges
und0t Regulatioo 3l of be SEBJ (List Othru IJ[$closura R lmmar1ts) Re ulati!ln&, 2015. Th.9 Ml
ormal i:lf ·the ·udil:ed Flnanclal im!ll.:s art, aveila :e en he Stack ,;chenge "' • ·ha!!ii, W\'1W.ns&100ia.~crn
and l'iww.bsemdia.com aml on 1he Ccmpany's web e WHW.bioc;on oom ¥eSl:or•relations and U,e same can
also he aooessed by scanning· QR cooo prouldad.
epaper.financialexpress.cone. • BENGALURU
filEJC\1 VIJAYAVANI
BENGALURU
ru~~d 7 ~rl~ 2026 I 7 AUGUST 2026
._, eJ
(Rs. in Million, except per equity share data)
3 months ended Year ended 3 months ended
Particulars 30.06.2026 31.03.2026 30.06.2025
Unaudited Audited Unaudited
I Revenue from operations 43,360 1,69,270 39,419
II Profit before exceptional items and tax 1,411 8,508 1,141
Ill Profit before tax 1,276 4,479 969
IV Profit attributable to shareholders of the Company 1,411 3,856 314
V Total comprehensive income/(loss) attributable to
shareholders of the Company 9,130 22,993 (1,735)
VI Paid-up equity share capital [Face value of Rs. 5 each] 8,148 8,105 6,685
VII Reserve as shown in the audited balance sheet 3,32,213
VIII Earnings per share [of Rs. 5 each] (not annualised) (annualised) (not annualised)
(a) Basic 0.87 2.82 0.26
(b) Diluted 0.87 2.82 0.26
1. Key standalone financial information
3 months ended Year ended 3 months ended
Particulars 30.06.2026 31.03.2026 30.06.2025
Unaudited Audited Unaudited
Revenue from o erations 6,245 23,464 5,371
II Profit before tax 699 510 76
Ill Net Profit for the period 522 372 (83)
2. The unaudited standalone and consolidated financial results for the quarter ended June 30, 2026 in respect of Biocon Limited ('the
Company') have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective
meetings held on August 05, 2026. The reports of the statutory auditors are unqualified.
3. These financial results have been prepared in accordance with Indian Accounting Standards ('Ind AS') prescribed under Section 133 of the
Companies Act, 2013 and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015.
4. The above is an extract of the detailed format of unaudited Financial Results filed with the Stock Exchanges
under Regulation 33 of the SEBI (Listing and Other Disclosure Requirements) Regulations, 2015. The full
format of the unaudited Financial Results are available on the Stock Exchange websites, www.nseindia.com
and www.bseindia.com and on the Company's website www.biocon.com/investor-relations and the same can
also be accessed by scanning the QR code provided.